首页 / 院系成果 / 成果详情页

Identification of potential mechanisms of quercetin in diabetic peripheral neuropathy through integrated network pharmacology and experimental validation  期刊论文  

  • 编号:
    3EC87BBE70823F84D27013D8E65055E7
  • 作者:
    Chen, Zanpeng#[1]Li, Ziyu#[1]Xue, Xiaowei[2];Song, Wei[3];Zhang, Rui[4];Wang, Chao(王超)[5]Yan, Bin[1];Sun, Qing*[1]Wu, Qunli*[1]
  • 语种:
    英文
  • 期刊:
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY ISSN:0028-1298 2026 年 ; 2026 JUN 9
  • 收录:
  • 关键词:
  • 摘要:

    Diabetic peripheral neuropathy (DPN) is a common complication of diabetes characterized by oxidative stress and neuroinflammation. Quercetin, a natural flavonoid with antioxidant properties, has shown potential in treating various nerve injuries, but its mechanisms in DPN remain unclear. This research aims to explore the potential therapeutic mechanisms of quercetin in DPN through network pharmacology and experimental validation. In this study, streptozotocin (STZ)-induced diabetic rats were treated with quercetin for 12 weeks. Behavioral tests and histopathological examination were performed to evaluate nociceptive behaviors and sciatic nerve pathology, and biochemical and molecular assays were used to assess oxidative stress, inflammation, and myelin-related markers. Bioinformatics and network pharmacology were used to predict relevant targets and pathways, followed by in vivo validation in sciatic nerve tissues and in vitro verification using high glucose-exposed RSC96 Schwann cells. Quercetin improved pain thresholds and sciatic nerve morphology without significantly altering blood glucose or body weight. Moreover, quercetin restored the remyelination-related gene expression and attenuated oxidative stress and inflammatory responses in DPN rats. Bioinformatics and network pharmacology analyses indicated that the TXNIP/NLRP3 signaling played a key role. Subsequent in vivo and in vitro experiments further supported that quercetin reduced TXNIP expression and downregulated NLRP3 inflammasome-related gene expression. Our results indicate that quercetin attenuates DPN-like manifestations and mitigates oxidative stress and neuroinflammation. Its potential mechanism may be related to the regulation of TXNIP/NLRP3 inflammasome-related signaling, which lays a foundation for further research on DPN treatment.

  • 推荐引用方式
    GB/T 7714:
    Chen Zanpeng,Li Ziyu,Xue Xiaowei, et al. Identification of potential mechanisms of quercetin in diabetic peripheral neuropathy through integrated network pharmacology and experimental validation [J].NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY,2026.
  • APA:
    Chen Zanpeng,Li Ziyu,Xue Xiaowei,Song Wei,&Wu Qunli.(2026).Identification of potential mechanisms of quercetin in diabetic peripheral neuropathy through integrated network pharmacology and experimental validation .NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY.
  • MLA:
    Chen Zanpeng, et al. "Identification of potential mechanisms of quercetin in diabetic peripheral neuropathy through integrated network pharmacology and experimental validation" .NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY(2026).
  • 入库时间:
    2026/6/17 8:23:14
  • 更新时间:
    2026/6/17 8:23:14
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:9 下载次数:0
浏览次数:9
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部